VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13

被引:131
作者
Kokame, K
Matsumoto, M
Fujimura, Y
Miyata, T
机构
[1] Natl Cardiovasc Ctr, Res Inst, Osaka 5658565, Japan
[2] Nara Med Univ, Dept Blood Transfus Med, Nara, Japan
关键词
D O I
10.1182/blood-2003-08-2861
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ADAMTS-13 was recently identified as a new hemostatic factor, von Willebrand factor (VWF)-cleaving protease. Either congenital or acquired defects of the enzymatic activity lead to thrombotic thrombocytopenic purpura (TTP). ADAMTS-13 specifically cleaves a peptidyl bond between Y1605 and M1606 in the A2 domain of VWF. Here, we determined the minimal region recognized as a specific substrate by ADAMTS-13. A series of partial deletions in the A2 domain flanked with N- and C-terminal tags were expressed in Escherichia coli and affinity-purified. These purified proteins were incubated with human plasma, subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and analyzed by Western blot. Judging from mobility shifts, all constructs except one were cleaved at the expected site. Data suggested that a minimal region as a functional substrate consisted of 73 amino acid residues from D1596 to R1668 of VWF, designated VWF73, and that further deletion of the E1660-R1668 region led to the loss of cleavage by ADAMTS-13. VWF73 was not cleaved by plasma from patients with congenital or acquired TTP, but cleaved by plasma from patients with hemolytic uremic syndrome, suggesting that VWF73 is a specific substrate for ADAMTS-13. Thus, VWF73 will be a useful seed to develop a new rapid assay to determine ADAMTS-13 activity.
引用
收藏
页码:607 / 612
页数:6
相关论文
共 42 条
[1]   ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13 [J].
Antoine, G ;
Zimmermann, K ;
Plaimauer, B ;
Grillowitzer, M ;
Studt, JD ;
Lämmle, B ;
Scheiflinger, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) :821-824
[2]   Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura [J].
Bianchi, V ;
Robles, R ;
Alberio, L ;
Furlan, M ;
Lämmle, B .
BLOOD, 2002, 100 (02) :710-713
[3]   Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13) [J].
Böhm, M ;
Vigh, T ;
Scharrer, I .
ANNALS OF HEMATOLOGY, 2002, 81 (08) :430-435
[4]   Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains [J].
Cal, S ;
Obaya, AJ ;
Llamazares, M ;
Garabaya, C ;
Quesada, V ;
López-Otín, C .
GENE, 2002, 283 (1-2) :49-62
[5]   Processing of von Willebrand factor by ADAMTS-13 [J].
Chung, DW ;
Fujikawa, K .
BIOCHEMISTRY, 2002, 41 (37) :11065-11070
[6]   IDENTIFICATION OF A CLEAVAGE SITE DIRECTING THE IMMUNOCHEMICAL DETECTION OF MOLECULAR ABNORMALITIES IN TYPE-IIA VONWILLEBRAND-FACTOR [J].
DENT, JA ;
BERKOWITZ, SD ;
WARE, J ;
KASPER, CK ;
RUGGERI, ZM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6306-6310
[7]   BINDING OF VONWILLEBRAND-FACTOR TO GLYCOPROTEIN-IB AND IIB/IIIA COMPLEX - AFFINITY IS RELATED TO MULTIMERIC SIZE [J].
FEDERICI, AB ;
BADER, R ;
PAGANI, S ;
COLIBRETTI, ML ;
DEMARCO, L ;
MANNUCCI, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (01) :93-99
[8]   Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family [J].
Fujikawa, K ;
Suzuki, H ;
McMullen, B ;
Chung, D .
BLOOD, 2001, 98 (06) :1662-1666
[9]   Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome [J].
Fujimura, Y ;
Matsumoto, M ;
Yagi, H ;
Yoshioka, A ;
Matsui, T ;
Titani, K .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) :25-34
[10]  
FUJIMURA Y, 1994, HAEMOSTASIS THROMBOS, P379